Systematic (IUPAC) name | |
---|---|
5-[2-(dimethylamino)ethyl]-2-phenyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
|
|
Clinical data | |
Legal status |
|
Routes of administration |
Oral |
Identifiers | |
CAS Number | 5845-26-1 3122-01-8 (hydrochloride) |
ATC code | None |
PubChem | CID: 22107 |
ChemSpider | 20775 |
UNII | 44G76ZB85O |
KEGG | D02699 |
ChEMBL | CHEMBL2111123 |
Synonyms | SQ-10,496 |
Chemical data | |
Formula | C19H22N2OS |
Molecular mass | 326.456 g/mol |
|
|
|
Tiazesim (INN; brand name Altinil), also known as thiazesim (BAN, USAN) or thiazenone, is a heterocyclic antidepressant related to the tricyclics which, first introduced in 1966 by Squibb Corporation (now Bristol-Myers Squibb), has since been discontinued and is no longer marketed.[1][2]
See also
References
- ^ C. R Ganellin; D. J Triggle; F.. Macdonald (1997). Dictionary of pharmacological agents. CRC Press. p. 1973. ISBN 978-0-412-46630-4. Retrieved 29 November 2011.
- ^ The United States patents quarterly. 1969. Retrieved 1 May 2012.
|